You have free access to this content

Value in Health

Cover image for Value in Health

January 2002

Volume 5, Issue 1

Pages 1–63

  1. Editorial

    1. Top of page
    2. Editorial
    3. Commentary
    4. Policy and Application
    5. Empirical Research
    6. Empirial Research
    7. Methodology
    8. Correspondence
    1. You have free access to this content
  2. Commentary

    1. Top of page
    2. Editorial
    3. Commentary
    4. Policy and Application
    5. Empirical Research
    6. Empirial Research
    7. Methodology
    8. Correspondence
    1. You have free access to this content
      Outcomes Research in the Health-Care System: Driven by Results (pages 3–4)

      The Cleveland Clinic Foundation

      Version of Record online: 21 MAR 2002 | DOI: 10.1046/j.1524-4733.2002.51002.x

  3. Policy and Application

    1. Top of page
    2. Editorial
    3. Commentary
    4. Policy and Application
    5. Empirical Research
    6. Empirial Research
    7. Methodology
    8. Correspondence
    1. You have free access to this content
      The Economics of Gene Therapy and of Pharmacogenetics (pages 5–13)

      Patricia Danzon and Adrian Towse

      Version of Record online: 21 MAR 2002 | DOI: 10.1046/j.1524-4733.2002.51081.x

    2. You have free access to this content
      Regulatory Issues for Health-Related Quality of Life— PhRMA Health Outcomes Committee Workshop, 1999 (pages 14–25)

      Nancy C. Santanello, Drew Baker, Joseph C. Cappelleri, Kati Copley-Merriman, Robert DeMarinis, Jean Paul Gagnon, Alice Hsuan, Joseph Jackson, Ramy Mahmoud, David Miller, Michael Morgan, Jane Osterhaus, Hugh Tilson and Richard Willke

      Version of Record online: 21 MAR 2002 | DOI: 10.1046/j.1524-4733.2002.51047.x

  4. Empirical Research

    1. Top of page
    2. Editorial
    3. Commentary
    4. Policy and Application
    5. Empirical Research
    6. Empirial Research
    7. Methodology
    8. Correspondence
    1. You have free access to this content
      The Direct Cost and Incidence of Systemic Fungal Infections (pages 26–34)

      Leslie S. Wilson, Carolina M. Reyes, Michelle Stolpman, Julie Speckman, Karoline Allen and Johnny Beney

      Version of Record online: 21 MAR 2002 | DOI: 10.1046/j.1524-4733.2002.51108.x

    2. You have free access to this content
      The Incidence and Cost of Hospitalization for 5-FU Toxicity among Medicare Beneficiaries with Metastatic Colorectal Cancer (pages 35–43)

      Thomas E. Delea, Montserrat Vera-Llonch, John S. Edelsberg, Lisa McGarry, Susan Anton, Marianne Ulcickas-Yood and Gerry Oster

      Version of Record online: 21 MAR 2002 | DOI: 10.1046/j.1524-4733.2002.51083.x

  5. Empirial Research

    1. Top of page
    2. Editorial
    3. Commentary
    4. Policy and Application
    5. Empirical Research
    6. Empirial Research
    7. Methodology
    8. Correspondence
    1. You have free access to this content
      Cost-Effectiveness Analysis of Interferon Beta in Multiple Sclerosis: A Markov Process Analysis (pages 44–54)

      Mark J. C. Nuijten and John Hutton

      Version of Record online: 21 MAR 2002 | DOI: 10.1046/j.1524-4733.2002.51052.x

  6. Methodology

    1. Top of page
    2. Editorial
    3. Commentary
    4. Policy and Application
    5. Empirical Research
    6. Empirial Research
    7. Methodology
    8. Correspondence
    1. You have free access to this content
      A Method for Identifying the Financial Burden of Hospitalized Infants on Families (pages 55–59)

      Shelah Leader, Phillip Jacobson, James Marcin, Ralph Vardis, Mark Sorrentino and Dennis Murray

      Version of Record online: 21 MAR 2002 | DOI: 10.1046/j.1524-4733.2002.51076.x

  7. Correspondence

    1. Top of page
    2. Editorial
    3. Commentary
    4. Policy and Application
    5. Empirical Research
    6. Empirial Research
    7. Methodology
    8. Correspondence
    1. You have free access to this content
      Letter to the Editor (pages 60–63)

      Version of Record online: 21 MAR 2002 | DOI: 10.1046/j.1524-4733.2002.51104.x

SEARCH

SEARCH BY CITATION